HomeInsights52 Week Low Stocks

Eris Lifesciences Ltd 52 Week Low

Eris Lifesciences Ltd 52 Week Low

stocks purchased

₹ 0.1 Cr

Volume transacted

stocks purchased

1.0 K

stocks traded

Last Updated time: 05 Nov 14:04 PM

Image

ERIS Lifesciences Ltd

NSE: ERIS

YEARLOW

810.1

Last updated on: Nov 04, 2024

Key Highlights

  • The 52 Week Low of ERIS Lifesciences Ltd is ₹ 810.1 as of 04 Nov 24.

Company Fundamentals for ERIS Lifesciences Ltd

No data available

Market price Over Time

1M

1Y

3Y

5Y

Monitoring ERIS Lifesciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
04 Nov 20241316.6
01 Nov 20241347.7
31 Oct 20241321
30 Oct 20241287.7
29 Oct 20241307.35
28 Oct 20241279.9
25 Oct 20241293.2
24 Oct 20241282.3
23 Oct 20241275.35
22 Oct 20241276.05

Asset Value vs Market Value of ERIS Lifesciences Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of ERIS Lifesciences Ltd

No data available

* All values are in crore

Historical Net Profit of ERIS Lifesciences Ltd

No data available

* All values are in crore

ERIS Lifesciences Ltd News Hub

News

Board of Eris Lifesciences approves acquisition of 30% stake in Levim Lifetech

The Board of Eris Lifesciences at its meeting held on 25 October 2024 has approved the exe...

Read more

25 Oct 202418:47

News

ERIS Lifesciences announces board meeting date

ERIS Lifesciences will hold a meeting of the Board of Directors of the Company on 25 Octob...

Read more

22 Oct 202415:56

News

ERIS Lifesciences to convene AGM

ERIS Lifesciences announced that the 18th Annual General Meeting (AGM) of the company will...

Read more

05 Aug 202418:42

News

ERIS Lifesciences announces board meeting date

ERIS Lifesciences will hold a meeting of the Board of Directors of the Company on 2 August...

Read more

31 Jul 202412:40

News

Eris Lifesciences allots 22,492 equity shares under ESOP

Eris Lifesciences has allotted 22,492 equity shares under ESOP on 20 June 2024. The paid u...

Read more

24 Jun 202412:26

News

Board of ERIS Lifesciences approves composite scheme of arrangement

The Board of ERIS Lifesciences at its meeting held on 21 May 2024 has approved composite s...

Read more

21 May 202418:42

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for 52 Week Low of ERIS Lifesciences Ltd

Why is it important to track the 52-week low of ERIS Lifesciences Ltd stocks?

Investors should monitor the 52-week low of ERIS Lifesciences Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to ERIS Lifesciences Ltd stocks hitting a 52-week low?

Factors leading to ERIS Lifesciences Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy ERIS Lifesciences Ltd stocks when they hit a 52-week low?

Buying ERIS Lifesciences Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of ERIS Lifesciences Ltd stocks?

Investors should monitor the 52-week low of ERIS Lifesciences Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying ERIS Lifesciences Ltd stock at their 52-week low?

An investor can analyze the reasons for the ERIS Lifesciences Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating ERIS Lifesciences Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating ERIS Lifesciences Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence ERIS Lifesciences Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*